SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

Back to all holdings Add to watchlist

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2023$230,937
-4.7%
14,7000.0%0.01%
+33.3%
Q1 2023$242,256
+5.6%
14,7000.0%0.01%
+50.0%
Q4 2022$229,320
-67.9%
14,700
-73.3%
0.00%
-66.7%
Q3 2022$714,000–55,050–0.01%–
 Download
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Bartlett & Co. LLC 20,781$2960.01%
Valued Wealth Advisors LLC 231$3,5740.00%
BALDWIN BROTHERS LLC/MA 2,035$29,0390.00%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders